EMA Releases Guideline on Lupus Trials

Drug Industry Daily
A A
For the first time, the European Medicines Agency has produced a guideline on clinical trial design for drugmakers developing targeted products to treat lupus — an effort by the EMA to encourage more companies to target the underserved disease.

To View This Article:

Login

Subscribe To Drug Industry Daily